SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-018295
Filing Date
2016-05-06
Accepted
2016-05-06 16:31:25
Documents
54
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aavl-10q_20160331.htm 10-Q 985993
2 EX-31.1 aavl-ex311_22.htm EX-31.1 16863
3 EX-32.1 aavl-ex321_23.htm EX-32.1 7474
  Complete submission text file 0001564590-16-018295.txt   4248484

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT aavl-20160331.xml EX-101.INS 937892
5 XBRL TAXONOMY EXTENSION SCHEMA aavl-20160331.xsd EX-101.SCH 33542
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aavl-20160331_cal.xml EX-101.CAL 37476
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aavl-20160331_def.xml EX-101.DEF 110820
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE aavl-20160331_lab.xml EX-101.LAB 278420
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aavl-20160331_pre.xml EX-101.PRE 210749
Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36579 | Film No.: 161628542
SIC: 2836 Biological Products, (No Diagnostic Substances)